Cargando…
Duloxetine in Affective Disorders: a Naturalistic Study on Psychiatric and Medical Comorbidity, Use in Association and Tolerability Across Different Age Groups
OBJECTIVE: Duloxetine, a selective serotonin and norepinephrine reuptake inhibitor (SNRI), is currently approved in many countries for the treatment of Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD). The present naturalistic study was aimed to investigate tolerability of Dulo...
Autores principales: | Dell’Osso, Bernardo, Camuri, Giulia, Dobrea, Cristina, Buoli, Massimiliano, Serati, Marta, Carlo Altamura, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496903/ https://www.ncbi.nlm.nih.gov/pubmed/23166563 http://dx.doi.org/10.2174/1745017901208010120 |
Ejemplares similares
-
Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study
por: Dell’Osso, Bernardo, et al.
Publicado: (2013) -
Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depression
por: Dell’Osso, Bernardo, et al.
Publicado: (2011) -
Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
por: Buoli, Massimiliano, et al.
Publicado: (2012) -
Duloxetine in panic disorder with somatic gastric pain
por: Preve, Matteo, et al.
Publicado: (2013) -
Clinical characteristics and long-term response to mood stabilizers in patients with bipolar disorder and different age at onset
por: Dell’Osso, Bernardo, et al.
Publicado: (2009)